Fmr LLC Spring Works Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 19,230 shares of SWTX stock, worth $903,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,230

Previous 11,204,799 99.83%

Holding current value

$903,617

Previous $494 Million 99.82%

% of portfolio

0.0%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$34.43 - $46.99 $385 Million - $526 Million	-11,185,569 Reduced 99.83%	19,230 $903,000
Q1 2025 May 12, 2025	BUY	$32.5 - $59.93 $1.52 Million - $2.81 Million	46,839 Added 0.42%	11,204,799 $494 Million
Q4 2024 Feb 13, 2025	BUY	$28.61 - $42.55 $486,770 - $723,945	17,014 Added 0.15%	11,157,960 $403 Million
Q3 2024 Nov 13, 2024	BUY	$32.04 - $42.76 $914,902 - $1.22 Million	28,555 Added 0.26%	11,140,946 $357 Million
Q2 2024 Aug 13, 2024	BUY	$36.06 - $47.62 $1.6 Million - $2.11 Million	44,365 Added 0.4%	11,112,391 $419 Million
Q1 2024 May 13, 2024	BUY	$36.5 - $52.5 $9.45 Million - $13.6 Million	258,791 Added 2.39%	11,068,026 $545 Million
Q4 2023 Feb 13, 2024	BUY	$18.94 - $37.24 $27 Million - $53 Million	1,423,764 Added 15.17%	10,809,235 $395 Million
Q3 2023 Nov 13, 2023	BUY	$23.12 - $31.38 $160,822 - $218,279	6,956 Added 0.07%	9,385,471 $217 Million
Q2 2023 Aug 11, 2023	BUY	$23.15 - $32.71 $85,608 - $120,961	3,698 Added 0.04%	9,378,515 $246 Million
Q1 2023 May 11, 2023	BUY	$24.97 - $34.05 $367,733 - $501,454	14,727 Added 0.16%	9,374,817 $241 Million
Q4 2022 Feb 13, 2023	SELL	$21.73 - $28.72 $1,521 - $2,010	-70 Reduced -0.0%	9,360,090 $243 Million
Q3 2022 Nov 10, 2022	BUY	$24.1 - $39.66 $46.9 Million - $77.3 Million	1,948,120 Added 26.28%	9,360,160 $263 Million
Q2 2022 Aug 12, 2022	BUY	$18.36 - $60.07 $25.1 Million - $82 Million	1,365,831 Added 22.59%	7,412,040 $182 Million
Q1 2022 May 13, 2022	BUY	$48.97 - $65.46 $103 Million - $137 Million	2,099,889 Added 53.21%	6,046,209 $341 Million
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $3.67 Million - $5.22 Million	-68,800 Reduced 1.71%	3,946,320 $245 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $2.94 Million - $4.14 Million	46,900 Added 1.18%	4,015,120 $255 Million
Q2 2021 Aug 13, 2021	BUY	$67.45 - $85.63 $268 Million - $340 Million	3,968,220 New	3,968,220 $327 Million

Others Institutions Holding SWTX

# of Institutions

265

Shares Held

71.9M

Call Options Held

11.8M

Put Options Held

1.27M

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.93B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account